Full Text View
Tabular View
No Study Results Posted
Related Studies
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity (Best PK/PD)
This study is currently recruiting participants.
Study NCT00607542   Information provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First Received: January 22, 2008   Last Updated: May 22, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Spasticity
Cerebral Palsy
Additional conditions recognized in this trial
Muscle Spasticity
More general conditions related to this trial
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases
Muscle Hypertonia
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Manifestations
Signs and Symptoms
Interventions listed in this trial
baclofen
More general drug interventions related to this trial
Central Nervous System Agents
GABA Agents
GABA Agonists
Molecular Mechanisms of Pharmacological Action
Muscle Relaxants, Central
Neuromuscular Agents
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services